Evidence map›Paper›PMID 37759924›Full record

ArticleBrain sciences2023

Relation of MRI-Visible Perivascular Spaces and Other MRI Markers of Cerebral Small Vessel Disease.

Frances Rodriguez Lara, Arturo Ruben Toro, Adlin Pinheiro, Serkalem Demissie, Oluchi Ekenze, Oliver Martinez, Pedram Parva, Andreas Charidimou, Saptaparni Ghosh, Charles DeCarli and 4 more

Abstract read
In one paragraph

Article in Brain sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Frances Rodriguez LaraChobanian & Avedisian School of Medicine, Boston University, Boston, MA 02118, USA.ORCID 0000-0002-2497-8965
Arturo Ruben ToroChobanian & Avedisian School of Medicine, Boston University, Boston, MA 02118, USA.
Adlin PinheiroDepartment of Biostatistics, School of Public Health, Boston University, Boston, MA 02118, USA.
Serkalem DemissieDepartment of Biostatistics, School of Public Health, Boston University, Boston, MA 02118, USA.
Oluchi EkenzeFramingham Heart Study, National Heart Lung and Blood Institute, Framingham, MA 01702, USA.ORCID 0000-0002-2510-8427
Oliver MartinezDepartment of Neurology, University of California Davis, Davis, CA 95817, USA.
Pedram ParvaDepartment of Radiology, Veterans Affairs Boston Healthcare System, Boston, MA 02118, USA.
Andreas CharidimouDepartment of Neurology, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA 02118, USA.
Saptaparni GhoshFramingham Heart Study, National Heart Lung and Blood Institute, Framingham, MA 01702, USA.
Charles DeCarliDepartment of Neurology, University of California Davis, Davis, CA 95817, USA.
Sudha SeshadriFramingham Heart Study, National Heart Lung and Blood Institute, Framingham, MA 01702, USA.
Mohamad HabesThe Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Sciences Center, San Antonio, TX 78229, USA.
Pauline MaillardDepartment of Neurology, University of California Davis, Davis, CA 95817, USA.
Jose Rafael RomeroFramingham Heart Study, National Heart Lung and Blood Institute, Framingham, MA 01702, USA.

Funding

UC Davis Alzheimer's Disease Core CenterP30AG010129 · NIA · UNIVERSITY OF CALIFORNIA DAVIS · PI DECARLI, CHARLES · 1991 to 2020
$28.3M
UC Davis Alzheimer's Disease Research CenterP30AG072972 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Charles DeCarli, Rachel A Whitmer · 2021 to 2026
$25.2M
PRECURSORS OF STROKE INCIDENCE AND PROGNOSISR01NS017950 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Hugo Javier Aparicio, Jose Rafael Romero · 1985 to 2026
$22.9M
EPIDEMIOLOGY OF DEMENTIA IN THE FRAMINGHAM STUDYR01AG008122 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA, SESHADRI, SUDHA · 1989 to 2015
$14.4M
Temporal Trends, Novel Imaging and Molecular Characterization of Preclinical and Clinical Alzheimer's Disease in the Framingham CohortsR01AG054076 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI DECARLI, CHARLES, SESHADRI, SUDHA · 2016 to 2020
$12.3M
Collaborative GWAS of Dementia, AD and related MRI and Cognitive EndophenotypesR01AG033193 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI SESHADRI, SUDHA · 2009 to 2016
$4.4M
Enlarged Perivascular Spaces as Markers of Vascular and Alzheimer pathology: predictors, pathophysiology and clinical consequencesR01AG059725 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ROMERO, JOSE RAFAEL · 2019 to 2023
$3.1M
Multiethnic machine learning brain signatures of ADRDR01AG080821 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI HABES, MOHAMAD · 2022 to 2025
$2.9M
Risk Factors, Genetics and Cognition in Cerebral Microbleeds: Framingham StudyK23AG038444 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ROMERO, JOSE RAFAEL · 2011 to 2015
$644k
Longitudinal Risk Factor Changes and Early Recognition of Cerebral Small Vessel DiseaseR21NS135268 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ROMERO, JOSE RAFAEL · 2023 to 2023
$454k
Cerebral Microbleeds in Young Adults: risk factors, biomarkers and geneticsR03AG048180 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ROMERO, JOSE RAFAEL · 2015 to 2016
$164k
WORD RETRIEVAL DEFICITS IN THE AGEDR01AG005972 · NIA · BRANDEIS UNIVERSITY · PI BOWLES, NANCY L · 1986 to 1994
–
NHLBI NIH HHS N01 HC025195NIA NIH HHS K23 AG038444NIA NIH HHS P30 AG010129NIA NIH HHS P30 AG072972NIA NIH HHS R01 AG008122NIA NIH HHS R01 AG033193NIA NIH HHS R01 AG054076NIA NIH HHS R01 AG059725NIA NIH HHS R01 AG059725; AG008122; AG054076; K23AG038444; R03 AG048180-01A1; AG033193NIA NIH HHS R01 AG080821NIA NIH HHS R03 AG048180NINDS NIH HHS R01 NS017950NINDS NIH HHS R01-NS017950-37NINDS NIH HHS R21 NS135268
6 · The paper itself

Abstract

Perivascular spaces (PVS) visible on brain MRI signal cerebral small vessel disease (CSVD). The coexistence of PVS with other CSVD manifestations likely increases the risk of adverse neurological outcomes. We related PVS to other CSVD manifestations and brain volumes that are markers of vascular brain injury and neurodegeneration. Framingham Heart Study (FHS) participants with CSVD ratings on brain MRI were included. PVS were rated in the basal ganglia (BG) and centrum semiovale (CSO) into grades I-IV and a category reflecting high burden in single or mixed CSO-BG regions. We related PVS to covert brain infarcts (CBI), white matter hyperintensities (WMH), cerebral microbleeds (CMB), total brain, hippocampal, and cortical gray matter volumes using adjusted multivariable regression analyses. In 2454 participants (mean age 54 ± 12 years), we observed that higher PVS burden in both BG and CSO was related to CMB in lobar and deep brain regions and increased WMH. Greater CSO PVS burden was associated with decreased total cortical gray volumes. PVS are associated with ischemic markers of CSVD and neurodegeneration markers. Further studies should elucidate the causality between PVS and other CSVD manifestations.

Indexed as

cerebral small vessel diseasedisease markerglymphatic functionMRI-visible perivascular spaces

Identifiers

PMID37759924
PMCPMC10527297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.